STERIS · 1 month ago
Remote Sales Representative (Ophthalmic)
United States
Full-time
Remote
Entry Level
$40K/yr - $80K/yr
1+ years expSTERIS is a company that helps create a healthier and safer world through innovative healthcare and life science solutions. The IMS Ophthalmic Remote Sales Representative will manage sales activities for a national territory, focusing on building customer relationships and achieving sales growth for the ophthalmic portfolio.
BiotechnologyHealth CareMedical Device
Responsibilities
Focus approximately 75-100% of the time prospecting new opportunities. Emphasis will be on outbound call activity
Collaborate with field sales and sales support teams to identify and close new business
Partner with field service teams assigned to territory including facilitating introductions with Customers
Attend Customer training events throughout the year such as Customer Learning Seminars
Responsible for providing the quarterly business reviews, proactive maintenance inspections, departmental evaluations, and in-services to accounts in territory either virtually or in person
Update the CRM system as required to document Customer information, sales activities, purchase orders
Resolve Customer service issues such as tracking down delayed repairs and billing issues and escalate as needed
Develop relationships with chapters of industry groups and GPOs within the territory
Qualification
Required
High School diploma
1 year of sales experience
Demonstrated knowledge of software (Word, Excel, PowerPoint, CRM)
Preferred
Bachelor's degree
3 years of outbound sales experience
Benefits
Base Salary + Incentive Compensation Program
Cell Phone Stipend
Robust Sales Training Program
Paid Time Off + 9 Corporate Holidays Per Year
Excellent Healthcare, Dental, and Vision Benefits
Healthcare and Dependent Flexible Spending Accounts
Long/Short Term Disability Coverage
401(k) with a Company Match
Parental Leave
Tuition Reimbursement Program
Additional Add-On Benefits/Discounts
Company
STERIS
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$0.28M2010-05-21Post Ipo Debt· $0.28M
1998-12-01IPO
Leadership Team
Daniel Carestio
President and CEO, STERIS
Walter Rosebrough
CEO Emeritus & Senior Advisor
Recent News
2026-02-05
GlobeNewswire
2026-01-22
2025-11-05
Company data provided by crunchbase